Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0)
# 5116
Out of 5,338 analysts
151
Total ratings
21.62%
Success rate
-41.27%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ZBIO Zenas BioPharma | Reiterates: Buy | 30 30 | 9.73 | 208.32% | 3 | May 16, 2025 | |
ADVM Adverum Biotechnolog... | Reiterates: Buy | 30 30 | 2.04 | 1370.59% | 6 | May 15, 2025 | |
MLYS Mineralys Therapeuti... | Reiterates: Buy | 42 42 | 15.38 | 173.08% | 8 | May 13, 2025 | |
SRZN Surrozen | Reiterates: Buy | 32 32 | 6.88 | 365.12% | 3 | May 12, 2025 | |
LENZ LENZ Therapeutics | Reiterates: Buy | 38 38 | 27.31 | 39.14% | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 20 | 3.48 | 474.71% | 9 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.99 | 910.1% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 4 4 | 0.76 | 426.32% | 8 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 2.15 | 365.12% | 12 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 1.01 | 1088.12% | 4 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 8 8 | 0.95 | 742.11% | 3 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.95 | 2.56% | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 3 | 3.33 | -9.91% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 12 2 | n/a | n/a | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 1.14 | 75.44% | 16 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 9 | 9.48 | -5.06% | 7 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 4.05 | 146.91% | 4 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 2 | 0.11 | 1718.18% | 7 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 36 36 | 3.19 | 1028.53% | 18 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 18 | n/a | n/a | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 28 | 223.43 | -87.47% | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 6 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Jul 18, 2022 |